Saudi Arabia Oxygen Concentrator Market: Home Healthcare Demand, Respiratory Care & Growth Outlook

The healthcare sector in Saudi Arabia is undergoing major shifts, and with that comes growing attention on respiratory care solutions. Oxygen concentrators – devices that extract and concentrate oxygen from ambient air for medical use – are becoming more essential as the Kingdom tackles rising chronic respiratory conditions, an expanding elderly population, and the modernization of healthcare infrastructure under Vision 2030. According to IMARC Group's latest data, the Saudi Arabia oxygen concentrator market size reached USD 33.1 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 52.0 Million by 2034, exhibiting a growth rate (CAGR) of 5.15% during 2026-2034.

These medical devices are used across hospitals, home care settings, and ambulatory centers to provide supplemental oxygen therapy for patients dealing with conditions like COPD, asthma, sleep apnea, and post-COVID complications. The market includes both portable and stationary units, with technologies ranging from continuous flow systems to pulse flow delivery. What's driving this expansion is a combination of better healthcare access, greater awareness about respiratory health, and the government's substantial push to strengthen the country's medical infrastructure.

Download the Sample Report to Understand Market Trends and Outlook

Oxygen Concentrator Market Growth Drivers:

● Rising Prevalence of Respiratory Diseases

Respiratory conditions have become a significant public health concern across Saudi Arabia. Studies show the prevalence rate of COPD stands at approximately 2,053 cases per 100,000 people, while asthma affects an estimated 14% of the population in certain regions. Between 1990 and 2019, the overall prevalence of COPD increased by 49%, with over 434,000 diagnosed cases reported. These conditions are driven by factors like high smoking rates (around 28% of adults over 40), exposure to air pollution, dust storms common in cities like Riyadh, and indoor biomass fuel use. As more patients require long-term oxygen therapy to manage symptoms and improve quality of life, demand for both portable and stationary oxygen concentrators continues to grow steadily.

● Government Healthcare Initiatives and Vision 2030 Investments

The Saudi government has committed serious resources to healthcare transformation as part of its Vision 2030 plan. In 2023 alone, Saudi Arabia allocated USD 50.4 billion (16.96% of the national budget) to healthcare, focusing on infrastructure expansion, privatization, and medical equipment procurement. One notable initiative saw USD 5 billion dedicated to health sector modernization, which includes purchasing oxygen concentrators and other critical medical devices. The Ministry of Health has integrated oxygen concentrators into the national COPD management strategy, aiming to reduce hospital admissions through home-based care. Additionally, policies promoting subsidies and insurance coverage for oxygen therapy equipment have made these devices more financially accessible to patients who need them.

● Aging Population and Shift Toward Home-Based Care

Saudi Arabia's demographic profile is changing. The population aged 60 and above is projected to rise from 5.5% in 2020 to 11% by 2030, increasing the number of individuals susceptible to age-related respiratory conditions. At the same time, there's a cultural and practical shift toward home healthcare – patients and families increasingly prefer managing chronic conditions at home rather than through repeated hospital visits. This trend is supported by the growing availability of portable oxygen concentrators that offer patients mobility and independence while maintaining therapeutic oxygen levels. The preference for home care is also driven by cost considerations, convenience, and the integration of telemedicine services that enable remote monitoring of patients using oxygen therapy at home.

Oxygen Concentrator Market Trends:

● Technological Advancements in Portable and Smart Devices

The oxygen concentrator market is seeing rapid innovation in device technology. Portable oxygen concentrators now feature longer battery life (up to 10 hours in some models), lighter designs, miniaturization using membrane technologies, and improved oxygen purity levels of 90-95%. Recent product launches include devices like the Oxymed P2 Portable Oxygen Concentrator and Inogen Rove 4, both featuring pulse-dose intelligent delivery technology that adjusts oxygen flow based on the patient's breathing patterns. These advancements reduce side effects like headaches and fatigue that were common with older models. Smart features such as real-time oxygen level monitoring, connectivity options for remote patient tracking, and integration with digital health platforms are becoming standard, making oxygen therapy more effective and patient-friendly.

● Strengthening Regulatory Framework and Quality Standards

The Saudi Food and Drug Authority (SFDA) plays a crucial role in maintaining the quality and safety of oxygen concentrators in the market. The regulatory body enforces compliance with international standards for medical devices, ensuring that both imported and locally assembled products meet stringent safety and performance criteria. This regulatory oversight has helped build trust among healthcare providers and patients. Additionally, the government is encouraging local manufacturing partnerships through public-private collaborations, aiming to reduce dependency on imports. Companies like Oxus Arabia are establishing manufacturing operations in the Kingdom, contributing to the localization goals outlined in Vision 2030 while also making products more readily available in the domestic market.

● Expansion of Distribution Channels and Accessibility

Access to oxygen concentrators is improving across Saudi Arabia as distribution networks expand beyond major cities. Government initiatives prioritize reaching remote and underserved areas where traditional hospital-based oxygen supply systems are limited. The rise of e-commerce platforms and specialized medical equipment suppliers has made it easier for patients to purchase or rent oxygen concentrators for home use. Ambulatory surgical centers and physician offices are also increasingly adopting these devices for outpatient procedures. Furthermore, public-private partnerships are facilitating the establishment of medical equipment distribution hubs in secondary cities, ensuring that patients throughout the Kingdom can access these life-saving devices without lengthy delays or logistical barriers.

Recent News and Developments in Oxygen Concentrator Market

• September 2024: Oxymed introduced its P2 Portable Oxygen Concentrator in India and regional markets, featuring five pulse flow settings, 90-95% oxygen purity, and up to 10 hours of battery life. This launch represents the broader trend of manufacturers focusing on compact, high-performance portable solutions that cater to active patients requiring mobility during oxygen therapy.
• October 2024: Inogen, Inc. launched the Inogen Rove 4 portable oxygen concentrator with pulse-dose intelligent delivery technology. The device adapts oxygen delivery based on varying respiratory patterns, offering patients enhanced comfort and efficiency. This innovation is particularly relevant for Saudi Arabia's growing home healthcare segment, where patients seek devices that provide personalized therapeutic support.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.